Newly engineered peptide shows potential as long-acting anti-HIV drug
Published Date: 12/5/2019
Source: sciencedaily.com
A newly engineered peptide called IBP-CP24 has the potential to be further developed as a long-acting anti-HIV drug that can be used alone or in combination with a broad neutralizing antibody for the treatment and prevention of HIV-1 infection, according to a new study.